ACE2 and COVID-19: These peptideinhibitors are composed of two sequential self-supporting α-helices(α1,2-helixes) generated from the ACE2 protease domain(PD) and may be employed as COVID-19 treatments.41 Furthermore, using the protease domain of ACE2, Pei etal.